Trial finds biomarker test could significantly reduce antibiotic use in sepsis

A groundbreaking UK patient trial, led by researchers from the University of Manchester, has demonstrated that using a new biomarker testing protocol for sepsis can enable doctors to safely shorten antibiotic treatment compared to current practices. The study found that reducing treatment duration by approximately 10% could yield significant benefits, including cost savings for healthcare systems, fewer adverse drug effects,…